Rense.com





Questions Raised Over Claim
Of MMR Vaccine Safety
Crucial Child Study Missed Many Cases, Say US Experts

By Jamie Doward
Social Affairs Editor
10-10-4
 
Serious questions were raised last night over the scientific evidence used by the government to reject claims of a link between the MMR vaccine and regressive autism in children.
 
A US paediatrician, Dr F Edward Yazbak, told The Observer that a study of more than 500,000 Danish children, regarded as the definitive analysis of the vaccine, should not be interpreted as ruling out a link between the jab and an increase in autism in Denmark.
 
UK government health officials have consistently referred to the 2002 study, sponsored by the US Centers for Disease Control and Prevention, to attack claims of a link between autism and the three-in-one vaccine for measles, mumps and rubella.
 
But Yazbak said his examination of the Danish data showed it could not be used to reject a link.
 
The study investigated 537,304 children born between 1991 and 1998. In Denmark, autism is normally diagnosed in children aged five or older. Many of those born after 1994 would not have been diagnosed by the time the study had concluded, Yazbak said.
 
'The most important age group to look at comprises children aged from five to nine. The number with autism increased from 8.38 per 100,000 before the MMR jab was introduced in 1987, to 77.43 in 2000.' Writing in the latest edition of the Journal of American Physicians and Surgeons, Yazbak and Dr Gary Goldman, concluded: 'The systematic error of missing a large number of autism diagnoses in the later years was a major shortcoming.
 
'Children with Asperger's syndrome and high-functioning autism, who have minimal speech and behaviour impairments and are thus not diagnosed as early as more profoundly affected children, are especially likely to be undercounted in this study.'
 
Dr Richard Horton, editor of the Lancet and author of a new book MMR, science & fiction said neither Yazbal's work or the Danish study could be used to prove or reject a link. 'There is a real danger of taking single studies in isolation and drawing conclusions one way or the other,' Horton said.
 
British doctor Andrew Wakefield first raised concerns about MMR in 1998 when he published a study based on just 12 children who had been referred to the Royal Free Hospital in Hampstead, north London, for gastrointestinal problems.
 
Wakefield's findings prompted him to consider whether there was a link between the MMR vaccine and autism and bowel disease, but the study was widely rejected by scientists.
 
Health campaigners blame the controversy for a decline in the number of children receiving the jab. Experts said there was a need to look at other explanations for the apparent rise in autism. Richard Mills, director of services of the National Autistic Society, said: 'There is an argument that rates of autism have not increased significantly but the diagnostic techniques and definitions have become more sophisticated. More research needs to be done.'
 
Yazbak pointed to newly published figures from the US that show 140,920 children aged six to 21 were diagnosed with autism last year, compared with 12,222 in 1993. 'You cannot keep saying the diagnostic criterion has changed when the diagnostic criterion was changed in the US in 1994, and we are in 2004.'
 
Yazbak denied his research proved a link between MMR and autism. But he said that, until further clinical research had been conducted, governments should offer a choice between single vaccines and the triple jab. A smaller study, published in the Lancet earlier this month, corroborated the Denmark findings. It looked at the vaccination records of 1,294 children diagnosed with autism and other disorders. The report also based its analysis on four other research projects and found no link.
 
Guardian Unlimited © Guardian Newspapers Limited 2004 http://www.guardian.co.uk/medicine/story/0,11381,1324083,00.html
 
 

Disclaimer






MainPage
http://www.rense.com


This Site Served by TheHostPros